Stocktoria
Immunovant, Inc. IMVT
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-05-14
Immunovant, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,916,127 | $129.8M | 2.41% |
| D. E. Shaw & Co., Inc. | 1,240,654 | $47.8M | 0.61% |
| RENAISSANCE TECHNOLOGIES LLC | 726,800 | $28.0M | 0.36% |
| MILLENNIUM MANAGEMENT LLC | 328,678 | $12.7M | 0.16% |
| CITADEL ADVISORS LLC | 285,323 | $11.0M | 0.14% |
| AQR CAPITAL MANAGEMENT LLC | 11,082 | $426,990 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.